CCI Approves Merger of Koninklijke DSM N.V. and Firmenich International SA

The Competition Commission of India (CCI) has officially approved the merger between Koninklijke DSM N.V. (DSM) and Firmenich International SA (Firmenich) under Section 31(1) of the Competition Act, 2002. This union brings together two major players in the nutrition, health, and bioscience sectors, promising significant developments in the industry.

CCI Approves Merger of Koninklijke DSM N.V. and Firmenich International SA

Introducing DSM-Firmenich: A New Industry Powerhouse

The proposed merger will result in the formation of DSM-Firmenich, a Swiss-domiciled company that will have its shares listed on Euronext Amsterdam. This strategic collaboration is expected to strengthen the position of both companies in their respective markets and bring new opportunities for growth and innovation.

1. DSM: A Leading Force in Nutrition, Health, and Bioscience

DSM, a public limited liability company, is incorporated under the laws of the Netherlands and headquartered in Heerlen. The company’s shares are traded on the Euronext Amsterdam Stock Exchange. DSM is known for its extensive activities in the fields of nutrition, health, and bioscience, offering a wide range of products and solutions for customers worldwide.

2. Firmenich: A Global Leader in Fragrances and Flavors

Firmenich, a privately owned company based in Geneva, Switzerland, specializes in the production and supply of fragrances, flavors, aroma chemicals, rosin resin, and turpentine. With a strong focus on innovation and sustainability, Firmenich has become a leading name in its industry.

Danube: A Subsidiary of DSM

In addition to the merger, DSM has established a wholly-owned subsidiary called Danube, registered in Switzerland. Although Danube is not currently engaged in any commercial activities, its creation may signal future expansion plans for the newly formed DSM-Firmenich.

Awaiting the CCI’s Detailed Order

The Competition Commission of India is expected to release a detailed order regarding the DSM and Firmenich merger shortly. The approval of this merger will likely have significant implications for the nutrition, health, and bioscience industries, with the potential to drive further advancements in these fields.

Tags:

Leave a Reply